Pharmaceutical giant Astra Zeneca has agreed to settle a gender pay bias claim, and the consent decree that spells out the terms of the settlement could affect North Carolina women who work for the company.
Under the settlement, 124 female pharmaceutical sales specialists will split $250,000.
A Department of Labor (DOL) investigation revealed that the women’s salaries averaged $1,700 less than their male counterparts.
As part of the settlement with the DOL’s Office of Federal Contract Compliance Programs, Astra Zeneca must also conduct a statistical analysis of the base pay of 415 individuals employed full time as “primary care” and “specialty care” level III pharmaceutical sales specialists in North Carolina and 12 other states and the District of Columbia. If the analysis concludes that the women continue to be underpaid, the company will adjust salaries accordingly.
Astra Zeneca must also update its affirmative action plan and maintain all appropriate documentation.